Kura Oncology
KURA
KURA
140 hedge funds and large institutions have $1.15B invested in Kura Oncology in 2023 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 44 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
140
Holders Change
+7
Holders Change %
+5.26%
% of All Funds
2.05%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
22
Increased
48
Reduced
44
Closed
15
Calls
$987K
Puts
$424K
Net Calls
+$563K
Net Calls Change
+$1.25M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$38.3M |
| 2 |
SI
Sofinnova Investments
Menlo Park,
California
|
$24M |
| 3 |
DM
Deerfield Management
New York
|
$76.4M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
$106M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
$10.8M |
Top Sellers
| 1 |
PM
Prosight Management
Dallas,
Texas
|
$13.7M |
| 2 |
AAA
Affinity Asset Advisors
New York
|
$2.75M |
| 3 |
Nuveen Asset Management
Chicago,
Illinois
|
$2.87M |
| 4 |
SCM
Suvretta Capital Management
New York
|
$99.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
$16.1M |
